Pathophysiology of migraine: a disorder of sensory processing

Cited by (1,001)

Items 301–400 of 1,001

1. Acute Migraine: Can the New Drugs Clinically Outpace?
   Alok D. Singh, Dhyuti Gupta, Ajaya Kumar Sahoo · 2020 · SN Comprehensive Clinical Medicine
2. Altered Gray Matter Volume and Functional Connectivity in Patients With Vestibular Migraine
   Xia Zhe, Xiaoling Zhang, Li Chen, Li Zhang, Min Tang, Dongsheng Zhang, Longchao Li, Xiaoyan Lei, Chenwang Jin · 2021 · Frontiers in Neuroscience
3. Clinical correlates of hypothalamic functional changes in migraine patients
   Roberta Messina, Maria Assunta Rocca, Paola Valsasina, Paolo Misci, Massimo Filippi · 2021 · Cephalalgia
4. Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain
   Jacob C. A. Edvinsson, Philip Victor Reducha, Majid Sheykhzade, Karin Warfvinge, Kristian Agmund Haanes, Lars IH Edvinsson · 2021 · Molecular Pain
5. Botulinum Toxin A for the Treatment of Photophobia and Dry Eye
   Ryan J. Diel, Zachary Kroeger, Roy C. Levitt, Constantine D. Sarantopoulos, Heather Sered, Jasmine Martinez‐Barrizonte, Anat Galor · 2017 · Ophthalmology
6. A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
   Peck, Jacquelin, Urits, Ivan, Zeien, Justin, Hoebee, Shelby, Mousa, Mohammad, Alattar, Hamed, Kaye, Alan D., Viswanath, Omar · 2020 · Current Pain and Headache Reports
7. Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
   Endang Mutiawati, Syahrul Syahrul, Marhami Fahriani, Jonny Karunia Fajar, Sukamto Salang Mamada, Helnida Anggun Maliga, Nur Samsu, Muhammad Ilmawan, Yeni Purnamasari, Anisa Asmiragani et al. · 2021 · F1000Research
8. Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor
   Gabriel Gárate, Vicente González‐Quintanilla, Andrea González, Marta Pascual, Sara Pérez‐Pereda, Jorge Madera, Julio Pascual · 2023 · Annals of Neurology
9. Individuals with migraine have a different dry eye symptom profile than individuals without migraine
   Monika Farhangi, Ryan J. Diel, Dawn C. Buse, Amy Michelle Huang, Roy C. Levitt, Constantine D. Sarantopoulos, Elizabeth Roy Felix, Anat Galor · 2019 · British Journal of Ophthalmology
10. Magnetic resonance imaging for chronic pain: diagnosis, manipulation, and biomarkers
    Yiheng Tu, Jin Cao, Yanzhi Bi, Li Hu · 2020 · Science China Life Sciences
11. Migraine: Calcium Channels and Glia
    Marta Kowalska, Michał Prendecki, Thomas Piekut, Wojciech P. Kozubski, Jolanta Dorszewska · 2021 · International Journal of Molecular Sciences
12. Application of EEG in migraine
    Ning Zhang, Yonghui Pan, Qihui Chen, Qingling Zhai, Ni Liu, Yanan Huang, Tingting Sun, Yake Lin, Linyuan He, Yue Hou et al. · 2023 · Frontiers in Human Neuroscience
13. Aura phenomena do not initiate migraine attacks—Findings from neuroimaging
    Jan Mehnert, Laura H. Fischer-Schulte, Arne May · 2023 · Headache The Journal of Head and Face Pain
14. Neurophysiological aspects of the trigeminal sensory system: an update
    Fréderic Van der Cruyssen, Constantinus Politis · 2017 · Reviews in the Neurosciences
15. The Posterior Insula Shows Disrupted Brain Functional Connectivity in Female Migraineurs Without Aura Based on Brainnetome Atlas
    Jilei Zhang, Jingjing Su, Mengxing Wang, Ying Zhao, Qiting Zhang, Yao Qian, Haifeng Lu, Hui Zhang, Gefei Li, Yi-Lan Wu et al. · 2017 · Scientific Reports
16. Patterns of Perceived Stress Throughout the Migraine Cycle: A Longitudinal Cohort Study Using Daily Prospective Diary Data
    Marina Vives‐Mestres, Amparo Casanova, Dawn C. Buse, Stephen Donoghue, Timothy T. Houle, Richard B. Lipton, Alec Mian, Kenneth J. Shulman, Serena Laura Orr · 2020 · Headache The Journal of Head and Face Pain
17. Long-Term Effects of Self-Administered Transcranial Direct Current Stimulation in Episodic Migraine Prevention: Results of a Randomized Controlled Trial
    Heiko Pohl, Marius Moisa, Hans-H. Jung, Kathrin Brenner, Jessica Aschmann, Franz Riederer, Christian Carl Ruff, Jean E. Schoenen, Roger Luechinger, Lukas L Widmer et al. · 2020 · Neuromodulation Technology at the Neural Interface
18. miR‐34a‐5p up‐regulates the IL‐1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons
    Hui Zhang, Xuemei Zhang, Dandan Zong, Xiaoying Ji, Hua Jiang, Feng‐zheng Zhang, Shengdong He · 2020 · FEBS Open Bio
19. OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
    Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Michail Vikelis · 2022 · Toxins
20. Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations
    Louise O’Hare, Luca Tarasi, Jordi M. Asher, Paul Barry Hibbard, Vincenzo Romei · 2023 · International Journal of Molecular Sciences
21. Migraine - a borderland disease to epilepsy: near it but not of it
    Jakob Paungarttner, Martina Quartana, Lucrezia Patti, Barbora Sklenárová, Fatemeh Farham, Inés Hernando Jiménez, Muazzez Gokcen Soylu, Irina Maria Vlad, Semı̇h Taşdelen, Teresa Mateu et al. · 2024 · The Journal of Headache and Pain
22. Migraine and stroke: correlation, coexistence, dependence - a modern perspective
    Michał Borończyk, Anna Zduńska, Julia Węgrzynek‐Gallina, Olga Grodzka, Anetta Lasek‐Bal, Izabela Domitrz · 2025 · The Journal of Headache and Pain
23. Transcriptional Alterations in the Trigeminal Ganglia, Nucleus and Peripheral Blood Mononuclear Cells in a Rat Orofacial Pain Model
    Tímea Aczél, József Kun, Éva Szőke, Tibor A. Rauch, Sini Junttila, Attila Gyenesei, Kata Bölcskei, Zsuzsanna Helyes · 2018 · Frontiers in Molecular Neuroscience
24. Lamotrigine in the Prevention of Migraine With Aura: A Narrative Review
    Dan Buch, Hugues Chabriat · 2019 · Headache The Journal of Head and Face Pain
25. Pathophysiology of Migraine
    Ana Recober · 2021 · CONTINUUM Lifelong Learning in Neurology
26. Specific activation of GluN1-N2B NMDA receptors underlies facilitation of cortical spreading depression in a genetic mouse model of migraine with reduced astrocytic glutamate clearance
    Giovanna Crivellaro, Angelita Tottene, Marina Vitale, Marcello Melone, Giorgio Casari, Fiorenzo Conti, Mirko Santello, Daniela Pietrobon · 2021 · Neurobiology of Disease
27. Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
    Peter James Goadsby, Luminita Constantin, Caty Ebel‐Bitoun, Iva Igracki Turudic, Simon Hitier, C. Amand-Bourdon, Andrew Stewart · 2021 · European Journal of Neurology
28. Prevalence of migraine among the general population, and its effect on the quality of life in Jeddah, Saudi Arabia
    Boshra Bamalan, Ahlam B. Khojah, Lujain Mohammed Alkhateeb, Ibtisam Gasm, Albandri A. Alahmari, Saleha A. Alafari, Marah A. Sindi, Khaled A. Yaghmour · 2021 · Saudi Medical Journal
29. Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms
    Nazia Karsan, Karthik Nagaraj, Peter James Goadsby · 2022 · The Journal of Headache and Pain
30. Rebalancing NOX2/Nrf2 to limit inflammation and oxidative stress across gut-brain axis in migraine
    Alessio Ardizzone, Anna Paola Capra, Alberto Repici, Marika Lanza, Valentina Bova, Nicoletta Palermo, Irene Paterniti, Emanuela Esposito · 2024 · Free Radical Biology and Medicine
31. Medication “underuse” headache
    Wanakorn Rattanawong, Alan M. Rapoport, Anan Srikiatkhachorn · 2024 · Cephalalgia
32. The role and interaction of hypothalamic-related neurotransmitters in migraine
    Ana Belen Salinas-Abarca, Mohammed Gamal‐Eltrabily, Marcela Romero‐Reyes, Simon Akerman · 2025 · The Journal of Headache and Pain
33. Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine
    Patrizia Ferroni, Piero Barbanti, Antonella Spila, Federica Fratangeli, Cinzia Aurilia, Luisa Fofi, Gabriella Egeo, Fiorella Guadagni · 2018 · Current Medicinal Chemistry
34. Update on the pathophysiology of cluster headache: imaging and neuropeptide studies
    Alina Buture, Jason W Boland, Lisa Dikomitis, Fayyaz Ahmed · 2019 · Journal of Pain Research
35. Primary headache disorders
    Peter James Goadsby · 2019 · Neurology Clinical Practice
36. Acid‐sensing ion channel 3 blockade inhibits durovascular and nitric oxide‐mediated trigeminal pain
    Christopher M. Holton, Lauren C. Strother, Isaac J. Dripps, Amynah A. A. Pradhan, Peter James Goadsby, Philip R. Holland · 2020 · British Journal of Pharmacology
37. NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice
    Katarzyna M. Targowska‐Duda, Akihiko Ozawa, Zachariah Bertels, Andrea Cippitelli, John Solomon Marcus, Hanna Mielke-Maday, Gilles Zribi, Amanda N. Rainey, Brigitte Lina Kieffer, Amynah A. A. Pradhan et al. · 2020 · Neuropharmacology
38. Selective amplification of ipRGC signals accounts for interictal photophobia in migraine
    Harrison M. McAdams, Eric A. Kaiser, Aleksandra Igdalova, Edda Briana Haggerty, Brett L. Cucchiara, David H. Brainard, Geoffrey K. Aguirre · 2020 · Proceedings of the National Academy of Sciences
39. Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats
    Razieh Kooshki, Mehdi Abbasnejad, Saeed Esmaeili‐Mahani, Maryam Raoof, Vahid Sheibani · 2020 · Neuropharmacology
40. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
    Cecilia Rustichelli, Flavia Lo Castro, Carlo Baraldi, Anna Ferrari · 2020 · Expert Opinion on Investigational Drugs
41. Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era
    Laura Rapisarda, Michele Trimboli, Francesco Fortunato, Antonio Martino, Oreste Marsico, Giulio Demonte, Antonio Augimeri, Angelo Labate, Antonio Gambardella · 2021 · Neurological Sciences
42. The selective 5‐HT1F receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache
    Marta Vila‐Pueyo, Keith J. Page, Paul R. Murdock, Howard J. Loraine, Amanda J. Woodrooffe, Kirk W. Johnson, Peter James Goadsby, Philip R. Holland · 2021 · British Journal of Pharmacology
43. Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
    Peter McAllister, Lois E. Lamerato, Lynda J. Krasenbaum, Joshua M. Cohen, Krishna Tangirala, Stephen Thompson, Maurice T. Driessen, Julian P. Casciano, Zenobia Dotiwala, Alexander Mauskop · 2021 · The Journal of Headache and Pain
44. Resting-state abnormalities in functional connectivity of the default mode network in migraine: A meta-analysis
    Su Hu, Zeqi Hao, Mengting Li, Mengqi Zhao, Jianjie Wen, Yanyan Gao, Qīng Wáng, Hongyu Xi, Collins Opoku Antwi, Xize Jia et al. · 2023 · Frontiers in Neuroscience
45. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside
    Dimos Dimitrios Mitsikostas, Christian Waeber, Margarita Sánchez del Río, Bianca Raffaelli, Håkan Ashina, Antoinette MaassenVanDenBrink, Anna P. Andreou, Patricia Pozo‐Rosich, Alan M. Rapoport, Messoud Ashina et al. · 2023 · Nature Reviews Neurology
46. Mitochondrial metabolism related markers GDF‐15, FGF‐21, and HIF‐1α are elevated in pediatric migraine attacks
    Yasemin Baranoğlu Kılınç, Erkan Kılınç, Ayşegül Danış, Fatma Hancı, Sevim Türay, Aynur Özge, Hayrünnisa Bolay · 2023 · Headache The Journal of Head and Face Pain
47. Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response
    Gabriella Juhász, Kinga Gecse, Dániel Baksa · 2023 · Pharmacology & Therapeutics
48. Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities
    S. Blitshteyn · 2023 · Current Neurology and Neuroscience Reports
49. Symptoms related to the visual system in migraine
    Robin M. van Dongen, Joost Haan · 2019 · F1000Research
50. Contribution of intraganglionic CGRP to migraine-like responses in male and female rats
    Erika Ivanna Araya, Joelle de Melo Turnes, Amanda Ribeiro Barroso, Juliana Geremias Chichorro · 2019 · Cephalalgia
51. Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: Perspectives from a tertiary referral headache unit
    Giulio Mastria, Valentina Mancini, Marco Di Cesare, Marta Puma, Michele Alessiani, Barbara Petolicchio, Alessandro Viganò, Vittorio Di Piero · 2020 · Cephalalgia
52. A Review on the Triggers of Pediatric Migraine with the Aim of Improving Headache Education
    Gaku Yamanaka, Shinichiro Morıchı, Shinji Suzuki, Soken Go, Mika Takeshita, Kanako Kanou, Yu Ishida, Shingo Oana, Hisashi Kawashima · 2020 · Journal of Clinical Medicine
53. Epilepsy in patients with familial hemiplegic migraine
    Buse Rahime Hasırcı Bayır, Kemal Tutkavul, Metin Eser, Betül B. Baykan · 2021 · Seizure
54. Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
    Damiana Scuteri, Maria Tiziana Corasaniti, Paolo Tonin, Pierluigi Nicotera, Giacinto Bagetta · 2021 · The Journal of Headache and Pain
55. Greater occipital nerve block modulates nociceptive signals within the trigeminocervical complex
    Jan Hoffmann, Jan Mehnert, Elena M Koo, Arne May · 2021 · Journal of Neurology Neurosurgery & Psychiatry
56. Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients
    Stefano Di Antonio, Lars Arendt‐Nielsen, Marta Ponzano, Francesca Bovis, Paola Torelli, Cinzia Finocchi, Matteo Castaldo · 2022 · Cephalalgia
57. Triggers of migraine: where do we stand?
    Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, Alessia Putortì, Cristina Tassorelli · 2022 · Current Opinion in Neurology
58. Migraine as an allostatic reset triggered by unresolved interoceptive prediction errors
    William Sedley, Sukhbinder Kumar, Siobhan Jones, Andrew D Levy, Karl John Friston, Timothy David Griffiths, Paul Goldsmith · 2024 · Neuroscience & Biobehavioral Reviews
59. Current Trends in Pediatric Migraine: Clinical Insights and Therapeutic Strategies
    Adnan Ahmed Khan, Sufang Liu, Feng Tao · 2025 · Brain Sciences
60. Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine
    Kjersti Grøtta Vetvik, E. Anne MacGregor, Christofer Lundqvist, Michael Bjørn Russell · 2018 · The Journal of Headache and Pain
61. Circadian Variation of Migraine Attack Onset: A Review of Clinical Studies
    Dániel Baksa, Kinga Gecse, Sahel Kumar, Zsuzsanna Tóth, Zsófia Gál, Xénia Gonda, Gabriella Juhász · 2019 · BioMed Research International
62. What's New in the Treatment of Migraine?
    Kathleen B. Digre · 2019 · Journal of Neuro-Ophthalmology
63. Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen
    Robert Paul Cowan, Noah B. Gross, Melanie D. Sweeney, Abhay P. Sagare, Axel Montagne, Xianghong Arakaki, Alfred Nji Fonteh, Berislav V. Zloković, Janice M. Pogoda, Michael G. Harrington · 2021 · Headache The Journal of Head and Face Pain
64. TREK Channel Activation Suppresses Migraine Pain Phenotype
    Pablo Ávalos Prado, Arnaud Landra-Willm, Clément Verkest, Aurore Ribera, Anne‐Amandine Chassot, Anne Baron, Guillaume Sandoz · 2021 · iScience
65. Calcitonin gene‐related peptide (CGRP) is a key molecule released in acute migraine attacks—Successful translation of basic science to clinical practice
    Lars IH Edvinsson · 2022 · Journal of Internal Medicine
66. Targeted Acid-Sensing Ion Channel Therapies for Migraine
    Nazia Karsan, Eric B. Gonzales, Gregory O. Dussor · 2018 · Neurotherapeutics
67. Workforce Gap Analysis in the Field of Headache Medicine in the United States
    Olivia Begasse de Dhaem, Rebecca C. Burch, Noah L. Rosen, Ken Shubin Stein, Elizabeth Loder, Robert E. Shapiro · 2020 · Headache The Journal of Head and Face Pain
68. An Update on Temporomandibular Disorders (TMDs) and Headache
    Marcela Romero‐Reyes, Gary D. Klasser, Simon Akerman · 2023 · Current Neurology and Neuroscience Reports
69. Clinical utility and prospective of TMS–EEG: Updated review from an international expert group
    Ulf Ziemann, Yang Bai, Fiona Mitchell Baumer, Mikkel M. Beck, Paolo Belardinelli, Daniele Belvisi, Stephan Bender, Til Ole Bergmann, Marta Bortoletto, Silvia Casarotto et al. · 2026 · Clinical Neurophysiology
70. CGRP – a target for acute therapy in migraine: Clinical data
    Roberta Messina, Peter James Goadsby · 2018 · Cephalalgia
71. Current understanding of premonitory networks in migraine: A window to attack generation
    Laura Helene Schulte, Kuan‐Po Peng · 2019 · Cephalalgia
72. Shift work and migraine: A systematic review
    Veruscka Leso, Paola Gervetti, Sara Mauro, Maria Carmela Macrini, Maria Luigia Ercolano, Ivo Iavicoli · 2020 · Journal of Occupational Health
73. Small-molecule CGRP receptor antagonists: A new approach to the acute and preventive treatment of migraine
    David Moreno‐Ajona, Abigail Pérez-Rodríguez, Peter James Goadsby · 2020 · Medicine in Drug Discovery
74. Preclinical studies investigating the neural mechanisms involved in the co‐morbidity of migraine and temporomandibular disorders: the role of CGRP
    Simon Akerman, Marcela Romero‐Reyes · 2020 · British Journal of Pharmacology
75. The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
    Xinyu Tao, Zeya Yan, Jiahao Meng, Wei Wang, Qiling Dai, Qiufeng Zhou, Zhifeng Wang, Zhong Wang · 2022 · The Journal of Headache and Pain
76. Association between the prognostic nutritional index and severe headache or migraine: a population-based study
    Cheng Peng, Lijie Gao, Kongyuan Wu, Xin Jiang, Xiwen Chen, Changling Li, Wenjing Ge, Li He, Ning Chen · 2022 · Nutritional Neuroscience
77. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections
    Ryan J. Diel, Jodi C. Hwang, Zachary Kroeger, Roy C. Levitt, Constantine D. Sarantopoulos, Heather Sered, Elizabeth Roy Felix, Jasmine Martinez‐Barrizonte, Anat Galor · 2018 · British Journal of Ophthalmology
78. An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
    Ivan Urits, Gavin Clark, Daniel An, Bredan Wesp, Rebecca Z. Zhou, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Anh L. Ngo, Alan D. Kaye et al. · 2020 · Pain and Therapy
79. Current perspectives on mitochondrial dysfunction in migraine
    Shraman Kumar Bohra, Raghu Ram Achar, Saravana Babu Chidambaram, Christophe Pellegrino, Jérôme Laurin, Mojgan Masoodi, Asha Srinivasan · 2022 · European Journal of Neuroscience
80. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina
    Frank Wojciechowski Blixt, Aneta Radziwon‐Balicka, Lars IH Edvinsson, Karin Warfvinge · 2017 · Experimental Eye Research
81. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
    Kasra Maasumi, Rebecca L. Michael, Alan M. Rapoport · 2018 · Drugs
82. α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia
    Hung‐Ruei Tzeng, Ming Tatt Lee, Pi‐Chuan Fan, Daniel E. Knutson, Tzu-Hsuan Lai, Werner Sieghart, James Minton Cook, Lih‐Chu Chiou · 2020 · Neurotherapeutics
83. Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels
    Johanna Kleeberg-Hartmann, Birgit Vogler, Karl Meßlinger · 2021 · The Journal of Headache and Pain
84. Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain
    Christian Ziegeler, Greta Brauns, Arne May · 2021 · Headache The Journal of Head and Face Pain
85. Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials
    Raffaele Ornello, Valeria Caponnetto, Susanna Ratti, Giulia D’Aurizio, Chiara Rosignoli, Francesca Pistoia, Michèle Ferrara, Simona Sacco, Aurora D’Atri · 2021 · The Journal of Headache and Pain
86. Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup
    Leyi Zhang, Chenglong Lu, Li Kang, Yingji Li, Wenjing Tang, Dengfa Zhao, Shengyuan Yu, Ruozhuo Liu · 2022 · The Journal of Headache and Pain
87. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
    Jacob C. A. Edvinsson, Aida Maddahi, Isabella Mai Christiansen, Philip Victor Reducha, Karin Warfvinge, Majid Sheykhzade, Lars IH Edvinsson, Kristian Agmund Haanes · 2022 · The Journal of Headache and Pain
88. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
    Gábor Nagy-Grócz, Ferenc Zádor, Szabolcs Dvorácskó, Zsuzsanna Bohár, Sándor Benyhe, Csaba Tömböly, Árpád Párdutz, László Vécsei · 2017 · International Journal of Molecular Sciences
89. The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
    Cédric Gollion, Roberto De Icco, David W. Dodick, Håkan Ashina · 2022 · The Journal of Headache and Pain
90. Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial
    Peter James Goadsby, Jessica Ailani, David W. Dodick, Amaal Jilani Starling, Chengcheng Liu, Yingyi Liu, Sung Yun Yu, Jonathan H. Smith, Elimor Brand‐Schieber, Joel M. Trugman · 2025 · Nature Medicine
91. The Effect of Regional Anesthetic Sphenopalatine Ganglion Block on Self‐Reported Pain in Patients With Status Migrainosus
    Dev G. Mehta, Megan C. Leary, Hussam A. Yacoub, Mohammed El‐Hunjul, Hope M. Kincaid, Vitaliy Koss, Katrina Wachter, Don Malizia, Barry Glassman, John Castaldo · 2018 · Headache The Journal of Head and Face Pain
92. Exposure to Blast Overpressure Impairs Cerebral Microvascular Responses and Alters Vascular and Astrocytic Structure
    Rania Abutarboush, Ming Gu, Usmah Kawoos, Saad Habib-E-Rasul Mullah, Ye Chen, Samantha Y. Goodrich, Margaret M. Lashof-Sullivan, Richard M. McCarron, Jonathan K. Statz, Randy Scott Bell et al. · 2019 · Journal of Neurotrauma
93. Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center
    Christian Ziegeler, Greta Brauns, Tim Patrick Jürgens, Arne May · 2019 · The Journal of Headache and Pain
94. Recent Advances in Pharmacotherapy for Episodic Migraine
    Calvin Chan, Peter James Goadsby · 2019 · CNS Drugs
95. NO up-regulates migraine-related CGRP via activation of an Akt/GSK-3β/NF-κB signaling cascade in trigeminal ganglion neurons
    Gang Yao, Yuhong Man, An-Ran Li, Guo Yu, Yun Dai, Ping Wang, Yifa Zhou · 2020 · Aging
96. No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine
    Charlotte Ernstsen, Sarah Louise Christensen, Jes Olesen, David M. Kristensen · 2020 · Cephalalgia
97. Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project
    Maria Clara Tonini, Alessandra Fiorencis, Rosario Iannacchero, Mauro Zampolini, Antonietta Cappuccio, Raffaella Raddino, Elisabetta Grillo, Maria Albanese, Gianni Allais, Marco Andrè Bassano et al. · 2021 · Neurological Sciences
98. The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain
    Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Miriam Francavilla, Roberto De Icco, Lara Ahmad, Cristina Tassorelli · 2022 · Headache The Journal of Head and Face Pain
99. Alterations in pain processing circuitries in episodic migraine
    Tiffani J. Mungoven, Kasia K. Marciszewski, Vaughan Gary Macefield, Paul M. Macey, Luke A. Henderson, Noemi Meylakh · 2022 · The Journal of Headache and Pain
100. Risk factors of white matter hyperintensities in migraine patients
     Jasem Al-Hashel, Raed Alroughani, Khaled Gad, Alsarraf Lamya, Samar Farouk Ahmed · 2022 · BMC Neurology